HLS Healius Limited
—Mkt Cap: —P/E: —1d ago
Healius Limited provides medical laboratory and pathology services in Australia. The company provides services under the Laverty Pathology, Dorevitch Pathology, Western Diagnostic Pathology, Genomic Diagnostic, Vetnostic…
Industry Peers
Medical Devices & SuppliesKey Statistics
Company
Market Cap—
Enterprise Value827.83M USD
Revenue (TTM)949.00M USD
Gross Profit295.92M USD
Net Income (TTM)-282.58M USD
Revenue/Share1.89 AUD
Last Price—
Fiscal Year EndJun 2026
MR QuarterJun 2026
Employees3.3K
CountryAU
SectorHealthcare
IndustryMedical Devices & Supplies
ISINAU0000033359
Valuation
P/E (Trailing)—
P/E (Forward)118.59
PEG1.60
EV/EBITDA20.03
EV/Revenue0.87
P/S0.20
P/B1.57
EPS (TTM)-0.56
EPS (Forward)0.00
52W Range
—
52W High—
52W Low—
Profitability
Gross Margin31.18%
Oper. Margin2.20%
EBITDA Margin4.35%
Profit Margin-30.26%
ROE-107.69%
ROA1.18%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF145.89M USD
CapEx (TTM)45.54M USD
FCF Margin9.63%
FCF Yield—
Net Debt642.16M USD
Net Debt/EBITDA15.54
Balance Sheet
Debt/Equity1.55
Current Ratio0.66
Quick Ratio0.54
Book Value/Sh0.24 AUD
Cash/Share0.09 AUD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 AUD
Div. Yield0.00%
5Y Avg Yield1.95%
Payout Ratio0.00%
Ex-Div DateMay 9, 2025
Pay Date—
Analyst Consensus
Rating3.2 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)0.5494 AUD
Target Range0.3500 AUD – 1.300 AUD
# Analysts10
Ownership
Shares Out.726.18M
Float562.02M
Insiders2.47%
Institutions114.37%
Technical
SMA 500.4175 AUD
SMA 2000.5213 AUD
Beta0.28
S&P 52W Chg16.44%
Avg Vol (30d)—
Avg Vol (10d)3.50M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—